Department of Genetics, Dr G Venkataswamy Eye Research Institute, Aravind Medical Research Foundation, #1 Anna nagar, Madurai, Tamilnadu, India.
BMC Ophthalmol. 2010 Feb 10;10:3. doi: 10.1186/1471-2415-10-3.
Mutations in COL8A2 gene which encodes the collagen alpha-2 (VIII) chain have been identified in both familial and sporadic cases of Fuchs endothelial corneal dystrophy (FECD). Heterozygous mutations in the SLC4A11 gene are also known to cause late-onset FECD. Therefore we screened for COL8A2, SLC4A11 gene variants in Indian FECD patients.
Eighty patients with clinically diagnosed FECD and 100 age matched normal individuals were recruited. Genomic DNA was isolated from peripheral blood leukocytes. Mutations in COL8A2, SLC4A11 coding regions were screened using bi-directional sequencing. Fischer's exact test or Pearson's chi squared test were used to predict the statistical association of genotypes with the phenotype.
Screening of COL8A2 gene revealed 2 novel c.1610G>A, c.1643A>G and 3 reported variations c.112G>A, c.464G>A and c.1485G>A. In SLC4A11 gene, novel c.1659C>T, c.1974C>T and reported c.405G>A, c.481A>C and c.639G>A variants were identified. However all the variations in both the genes were also present in unaffected controls.
This is the first study analysing COL8A2 gene in Indian patients with FECD. No pathogenic mutations were identified in COL8A2. Merely silent changes, which showed statistically insignificant association with FECD, were identified in the screening of SLC4A11 gene. These results suggest that COL8A2, SLC4A11 genes may not be responsible for FECD in patients examined in this study.
COL8A2 基因编码胶原 α-2(VIII)链的突变已在家族性和散发性 Fuchs 内皮角膜营养不良(FECD)病例中被鉴定出来。SLC4A11 基因突变也已知会导致晚发性 FECD。因此,我们在印度 FECD 患者中筛选 COL8A2、SLC4A11 基因突变。
招募了 80 名临床诊断为 FECD 的患者和 100 名年龄匹配的正常个体。从外周血白细胞中分离基因组 DNA。使用双向测序筛选 COL8A2、SLC4A11 编码区的突变。Fisher 确切检验或 Pearson 卡方检验用于预测基因型与表型的统计学关联。
筛选 COL8A2 基因显示 2 个新的 c.1610G>A、c.1643A>G 和 3 个报道的变异 c.112G>A、c.464G>A 和 c.1485G>A。在 SLC4A11 基因中,鉴定出新的 c.1659C>T、c.1974C>T 和报道的 c.405G>A、c.481A>C 和 c.639G>A 变体。然而,这两个基因中的所有变异在未受影响的对照组中也存在。
这是首次在印度 FECD 患者中分析 COL8A2 基因的研究。在 COL8A2 中未鉴定出致病性突变。在 SLC4A11 基因的筛选中仅发现了与 FECD 无统计学显著关联的沉默变化。这些结果表明,在本研究中检查的患者中,COL8A2、SLC4A11 基因可能不是 FECD 的原因。